Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial-Reference-Cited by-同舟云学术

Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial

Published:2012-03 Issue:2 Volume:36 Page:313-317
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Kusumi Ichiro,Honda Minoru,Uemura Keiichi,Sugawara Yasuhumi,Kohsaka Masako,Tochigi Akihiko,Koyama Tsukasa

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference23 articles.

1. Consensus development conference on antipsychotic drugs and obesity and diabetes;J Clin Psychiatry,2004

2. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients;Arranz;Hum Psychopharmacol Clin Exp,2007

3. Patients’ preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study;Bitter;World J Biol Psychiatry,2010

4. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS study;Bobes;Schizophr Res,2007

5. Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial;Chawla;Hum Psychopharmacol Clin Exp,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formulation and optimization of olanzapine-carboxylic acid cocrystals orodispersible tablets: In-vitro/ In-vivo study;Journal of Drug Delivery Science and Technology;2024-10

2. Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment;Medicni perspektivi;2024-04-01

3. A Systematic Review on the Effectiveness of Antipsychotic Drugs on the Quality of Life of Patients with Schizophrenia;Brain Sciences;2023-11-10

4. Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects;Clinical Drug Investigation;2021-03-09

5. Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis;Scientific Reports;2020-10-12